We only have this paper's title and publication details.
Read it at the sourceDiabetes is an independent risk factor for infection in IBD patients using immunomodulator therapy.
No takes yet. Share an insight, caveat, or question.
Ananthakrishnan et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: